National Institute on Drug Abuse; Amended Notice of Meeting, 66948 [2013-26622]
Download as PDF
<![CDATA[
66948
Federal Register / Vol. 78, No. 216 / Thursday, November 7, 2013 / Notices
Dated: November 1, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26623 Filed 11–6–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Board of Scientific
Counselors, NIDA, October 22, 2013,
08:00 a.m. to October 22, 2013, 06:00
p.m., Intramural Research Program,
National Institute on Drug Abuse, NIH,
Johns Hopkins Bayview Campus,
Baltimore, MD, 21223 which was
published in the Federal Register on
September 10, 2013, 78, 175 FR2013–
21947.
The date of the meeting is changed to
December 19, 2013. The meeting is
closed to the public.
Dated: November 1, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26622 Filed 11–6–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information on the Office
of Disease Prevention Draft Strategic
Plan for Fiscal Years 2014–2018
The purpose of this Request
for Information (RFI) is to seek broad
public input on the draft Strategic Plan
for Fiscal Years (FY) 2014–2018 for the
Office of Disease Prevention (ODP),
National Institutes of Health (NIH).
DATES: To ensure consideration,
responses must be received by
November 22, 2013.
ADDRESSES: Comments must be
submitted electronically using the webbased form available at https://
prevention.nih.gov/aboutus/strategic_
plan/rfi.aspx.
FOR FURTHER INFORMATION CONTACT:
Please direct all inquiries to Wilma
Peterman Cross, M.S.; Senior Public
Health Advisor, Office of Disease
Prevention,
National Institutes of Health; Phone:
301–496–1508; email: prevention@
mail.nih.gov.
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:24 Nov 06, 2013
Jkt 232001
The
mission of the ODP is to improve the
public health by increasing the scope,
quality, dissemination, and impact of
prevention research supported by the
NIH. The ODP fulfills this mission by
providing leadership for the
development, coordination, and
implementation of prevention research
in collaboration with NIH Institutes and
Centers and other partners. The Office is
responsible for advising the Director of
the NIH regarding prevention research
issues, actions, and activities. The
Office also provides overall guidance to
the NIH Institutes and Centers on
biomedical programs that seek to
improve the nation’s health through
research, training, knowledge
translation, and public education as
they relate to prevention.
Prevention research at the NIH
encompasses both primary and
secondary prevention. It includes
research designed to promote health; to
prevent onset of disease, disorders,
conditions, or injuries; and to detect and
prevent the progression of
asymptomatic disease. Prevention
research targets biology, individual
behavior, factors in the social and
physical environments, and health
services and informs and evaluates
health-related policies and regulations.
Prevention research includes studies
for:
• Identification and assessment of
risk and protective factors;
• Screening and identification of
individuals and groups at risk;
• Development and evaluation of
interventions to reduce risk;
• Translation, implementation, and
dissemination of effective preventive
interventions into practice; and
• Development of methods to support
prevention research.
Although established in 1986 in
response to a directive in the Health
Research Extension Act of 1985, the
Office has never had a formal strategic
plan. The ODP implemented an
extensive and inclusive process to
develop a strategic plan that would
outline the priorities for the Office over
the next five years and highlight the
ODP’s role in advancing prevention
research at the NIH. Feedback was
solicited from multiple stakeholder
communities including academia,
industry, health care professionals,
patient advocates and advocacy
organizations, scientific and
professional organizations, federal
agencies, and other interested members
of the public. Based on this feedback,
six strategic priorities were selected as
the framework for the plan. The
priorities represent the breadth of the
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
ODP portfolio and allow for emerging
areas of opportunity to be incorporated
into Office activities.
Information Requested
This RFI is intended to gather broad
public input on the ODP Draft Strategic
Plan for FY 2014–2018. While feedback
is welcome on any part of the draft
document, comments on the six
strategic priorities and related objectives
are encouraged. The ODP invites input
from prevention researchers in
academia and industry, health care
professionals, patient advocates and
advocacy organizations, scientific or
professional organizations, federal
agencies, and other interested members
of the public. Organizations are strongly
encouraged to submit a single response
that reflects the views of their
organization and membership as a
whole.
How To Submit a Response
To ensure consideration, responses
must be received by November 22, 2013,
and should be submitted electronically
using the web-based form available at
https://prevention.nih.gov/aboutus/
strategic_plan/rfi.aspx. The web form
will provide confirmation of response
submission, but respondents will not
receive individualized feedback. All
respondents are encouraged to sign up
for the ODP email list at https://
prevention.nih.gov/subscribe to receive
information related to Office activities,
including updates on the development
and release of the final strategic plan.
Responses to this RFI are voluntary
and may be submitted anonymously.
Please do not include any personally
identifiable or other information that
you do not wish to make public.
Proprietary, classified, confidential, or
sensitive information should not be
included in responses. Comments
submitted will be compiled for
discussion and incorporated into the
ODP strategic plan as appropriate. Any
personal identifiers (personal names,
email addresses, etc.) will be removed
when responses are compiled.
This RFI is for informational and
planning purposes only and is not a
solicitation for applications or an
obligation on the part of the U.S.
government to provide support for any
ideas identified in response to it. Please
note that the U.S. government will not
pay for the preparation of any
information submitted or for use of that
information.
E:\FR\FM\07NON1.SGM
07NON1
]]>Agencies
[Federal Register Volume 78, Number 216 (Thursday, November 7, 2013)]
[Notices]
[Page 66948]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26622]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Board of
Scientific Counselors, NIDA, October 22, 2013, 08:00 a.m. to October
22, 2013, 06:00 p.m., Intramural Research Program, National Institute
on Drug Abuse, NIH, Johns Hopkins Bayview Campus, Baltimore, MD, 21223
which was published in the Federal Register on September 10, 2013, 78,
175 FR2013-21947.
The date of the meeting is changed to December 19, 2013. The
meeting is closed to the public.
Dated: November 1, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-26622 Filed 11-6-13; 8:45 am]
BILLING CODE 4140-01-P
